Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
University of Washington
University of Washington
University of Washington
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
University of Washington
University of California, San Francisco
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Arizona
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Medical College of Wisconsin
City of Hope Medical Center
Universität des Saarlandes
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Stanford University
City of Hope Medical Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
City of Hope Medical Center
University of Kansas Medical Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
Fifth Affiliated Hospital, Sun Yat-Sen University
The First Affiliated Hospital of Soochow University
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Washington
Shanghai Pudong Hospital
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center